| What is RSS feed? | About Us |
 |
 Search Score: 4/10
Source: www.moreover.com --- 1 day ago
PHILADELPHIA, Sept. 5 /PRNewswire/ -- Breastcancer. ... Source: www.ncbi.nlm.nih.gov --- 1 hour ago
[Subcutaneous mastectomy with reduction mammaplasty--challenge for the surgeon and possible alternative for Breast Cancer Patients] Khirurgiia (Sofiia). 2006;(1):17-20 Authors: INTRODUCTION: Breast Cancer surgery with Breast removal is associated with critical decrease in women quality of life. Oncoplastic surgery offer different techniques for removal of the tumor and remodelating the Breast to achieve acceptable end results--oncological and aesthetical ones. MATERIAL AND METHODS: We present the clinical case of M.G. M -72 year old, St.IIIA--Breast Cancer patient, who refuses removal of the Breast and any chemotherapy. RESULTS: We perform subcutaneous mastectomy through inverted T - incision, including the areolo - mammilary complex in mastectomy specimen; L1, L2, L3 - lymphadenectomy through lateral skin flap. Skin - island flap was designed, based on superior flap for areolar replacement. Areolar reconstruction and reduction for symmetry were planed as a second step procedure because of the patient informed consent. CONCLUSIONS: 1. Subcutaneous mastectomy with reduction mammaplasty is an acceptable and possible operative way for Breast Cancer patient. 2. Preoperative planning is critical for best end results. 3. All precautions must by take for primary wound healing to achieve best time between operation and postoperative irradiation. 4. Further researches are needed to evaluate late aesthetic and oncologic results. PMID: 18771130 [ ... Source: www.ncbi.nlm.nih.gov --- 1 hour ago
Related Articles No indications of cognitive side-effects in a prospective study of Breast Cancer Patients receiving adjuvant chemotherapy. Psychooncology. 2008 Aug 29; Authors: Mehlsen M, Pedersen AD, Jensen AB, Zachariae R Objective: A number of cross-sectional studies have reported reduced cognitive function in Cancer Patients receiving chemotherapy compared with other Cancer Patients and healthy controls, suggesting that chemotherapy could be associated with cognitive side-effects. Recently published prospective studies question this hypothesis, but it is still unclear whether Cancer Patients should regard cognitive problems as a potential risk when receiving chemotherapy.Methods: In the present study we examine whether Cancer Patients (n=34) receiving chemotherapy differed in cognitive changes during treatment compared with cardiac Patients (n=12) and healthy controls (n=12) tested at 3-4 months interval.Results: Our results showed no differences with respect to changes in cognitive performance over time between Cancer Patients in chemotherapy, cardiac Patients, and healthy controls. In addition, the number of individuals showing reliable decline or improvement on cognitive tests did not differ between groups.Conclusion: Taken together, our results do not support a hypothesis of cognitive side-effects of standard-dose chemotherapy in Breast Cancer Patients. Copyright (c) 2008 John Wiley & Sons, Ltd. PMID: 18756583 [PubMed - as sup ... Source: www.ncbi.nlm.nih.gov --- 1 day ago
Related Articles Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial. J Clin Oncol. 2008 Sep 2; Authors: Bartlett JM, Munro A, Cameron DA, Thomas J, Prescott R, Twelves CJ PURPOSE: Patients with early Breast Cancer who receive anthracycline-containing chemotherapy experience improved relapse-free (RFS) and overall survival (OS) compared with those who receive non-anthracycline-containing chemotherapy. Such benefit, however, may be restricted to women whose tumors have specific molecular characteristics. We tested the hypothesis that HER2, epidermal growth factor receptor (EGFr)/HER1, HER3, Ki67, and topoisomerase IIalpha expression are predictive of outcome after anthracycline-based chemotherapy. METHODS: Tissue microarrays from 322 of 374 women in the BR9601 trial, which compared cyclophosphamide, methotrexate, and fluorouracil (CMF) with epirubicin followed by CMF (epi-CMF), were analyzed for HER1, 2, 3, 4; Ki67; and topoisomerase IIalpha protein expression and for HER2/topoisomerase IIalpha gene amplification. Their relationships to RFS and OS were investigated, and multiple regression analysis was used to identify interactions. RESULTS: A significant interaction was seen between tumors with normal HER1, HER2 fluorescent in situ hybridization (FISH), or HER3 levels and the enhanced benefit from epi-CMF versus CMF for RFS (hazard r ... Source: www.usatoday.com --- 4 hours ago
A new Breast Cancer study raises a provocative question: Can you ever have too much information? The study focuses on MRI scans, ... ... Source: www.prnewswire.com --- 2 hours ago
...
Source: www.topix.com --- 1 day ago
Main Category: Breast Cancer Also Included In: Clinical Trials / Drug Trials Article Date: 05 Sep 2008 - 4:00 PDT Agendia, a world leader in molecular Cancer diagnostics, announced the launch of TargetPrint , a ... ... Source: www.topix.com --- 1 day ago
Breast Cancer Patients have been offered new hope after scientists discovered a kidney Cancer drug could help boost other treatments when the effects start to wear off. ... Source: www.ncbi.nlm.nih.gov --- 1 day ago
Related Articles Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate Cancer-specific death in men with long-term follow-up after radical prostatectomy. Int J Cancer. 2008 Sep 2; Authors: Isharwal S, Miller MC, Epstein JI, Mangold LA, Humphreys E, Partin AW, Veltri RW Abnormal DNA content in tumor cells represents large scale chromosomal alterations and reflects later changes of genetic instability. Her-2/neu oncogene is amplified in 20-30% of Breast and ovarian Cancer Patients and is associated with poor prognosis. Therefore, we evaluated prognostic value of Her-2/neu expression and DNA content measurements in 252 clinically localized PCa Patients with long-term follow-up after radical prostatectomy for progression, metastasis and PCa-specific death. Her-2/neu expression was determined by immunohistochemistry and DNA content measurements employed Feulgen-stained Cancer nuclei captured using static image cytometry system. Cox proportional hazard regression and Kaplan-Meir plots were used to identify significant prognostic factors for progression, metastasis and PCa-specific death. The proportions of Her-2/neu positive and high %DNA index tumors significantly increased from nonprogressor to progressors without metastasis to progressors with metastasis (p < 0.0001; <0.0001). Further, the proportions of Her-2/neu positive and high %DNA index tumors significantly increased from Patients who died from another ... Source: www.ncbi.nlm.nih.gov --- 5 hours ago
Related Articles [Preliminary outcome of Breast Cancer located at the lower quadrant treated with a thoracomammary flap] Bull Cancer. 2008 Aug;95(7):773-8 Authors: Renouvel F, Nos C, Clough KB, Lecuru F Conservative surgical treatment with wide local excision of lower pole Breast carcinoma is a major factor of poor cosmetic results. We propose reconstruction of the inferior part of the Breast using a fascio-cutaneous flap during excision of lower pole cancers, particularly in cases of women with small-sized breasts. In 2005, 14 Patients were selected to undergo conservative Breast surgery with fasciocutaneous flap taken from the fatty area found below the thoraco-mammary fold. This area of tissue was de-epedermized and the rotated to fill the Breast defect. Patient were followed to determine carcinologic and cosmetic result as one year. All Patients had invasive carcinoma. Mean volume of existed tissue was 43 cm3. Margins were adequate for 12 Patients and the final 2 Patients in the serie had to undergo mastectomy for involved margins. At one year, cosmetic results were graded as good by both the surgeon and the Patients. Mammograms were satisfactory except for one case of partial liposclerosis of the flap. Preliminary results showed feasibility and relevance of this new technique for Breast Cancer located at the lower pole. PMID: 18755654 [PubMed - indexed for MEDLINE] ... Source: www.irishexaminer.com --- 1 day ago
SERVICES to treat psychological distress in Cancer Patients are still largely unstructured, under-resourced and delivered in an ad hoc fashion, a conference for Breast Cancer survivors will hear today. ... Source: digital50.com --- 1 day ago
NASHVILLE, Tenn.-(Business Wire)-September 5, 2008 - Sarah Cannon Research Institute (SCRI) investigators have found that "smart bomb" therapies are effective in treating Breast Cancer Patients while minimizing side effects. Howard A. Burris III, M.D., SCRI's chief medical... ... Source: www.pjstar.com --- 4 hours ago
The government on Friday began posting a list of prescription drugs under investigation for potential safety problems in an effort to better inform doctors and Patients. Drugs under investigation Medications with possible safety issues Drugs under investigation by the Food and Drug Administration, what they are used for and the potential problem: • R-Gene 10 , a growth hormone; pediatric overdose due to labeling/packaging confusion. • Suprane , an anesthetic; cardiac arrest. • Cymbalta , for depression and other conditions; urinary retention. • Intelence , an HIV medication; bleeding into joints. • Carac and Kuric , creams for skin conditions and fungal infections; name confusion. • Heparin , a blood-thinner; serious allergic reactions. • Extraneal , used in kidney dialysis; low blood sugars. • Humulin R (U-500) , insulin for diabetes; dosing confusion. • Stromectol and Warfarin , an anti-parasite drug and a blood thinner; drug interaction. • Tykerb , for advanced Breast Cancer; liver damage. • Revlimid , for multiple myeloma; severe skin blistering and bleeding. • Tysabri , for multiple sclerosis; skin melanomas. • Nitrostat , for angina; overdose due to labeling confusion. • Sandostatin LAR , for abnormal bone growth; bowel obstruction. • Oxycontin , a pain killer; drug misuse, abuse and overdose. • Definity , used in cardiac imaging; cardiopulmonary reactions. • Dilantin injection , for epileptic seizures; serious skin reaction ... Source: www.ctdispatch.com --- 1 day ago
Colleton Medical Center will be offering digital mammography at its facility this Fall. The innovative digital system provides outstanding image quality and clear, highly detailed images of the Breast which enables physicians to detect and diagnose Breast Cancer in Patients with confidence. Colleton Medical Center’s new Senographe® DS full-field digital mammography system is the most modern [...] ... Source: messageboard.gulfcoastbands.com --- 1 day ago
All Aboard! a tribute to Johnny Cash is coming with covers from bands like The Loved Ones, MXPX, Chuck Ragan, Gaslight Anthem and more. All Aboard: A Tribute To Johnny Cash To Be Released October 21st On Anchorless Records Punk/Indie Greats Honor The Man In Black Lineup Includes: The Bouncing Souls, The Dresden Dolls (Feat. Franz Nicolay Of The Hold Steady), The Gaslight Anthem, The Sainte Catherines, Ben Nichols Of Lucero, Chuck Ragan And Many More! Anchorless Records To Donate All Profits To The Syrentha Savio Endowment (SSE) Non-Profit Organization Providing Financial Assistance To Underprivileged Breast Cancer Patients SEPTEMBER 3, 2008 LOS ANGELES, CA: All aboard the Johnny Cash Express! Boasting a lineup of punk and alternative rock's most indie minded artists, proudly wearing their hearts on their sleeves while effortlessly blending Punk Rock with Americana, this new homage to the spirit of Johnny Cash is good for the soul and for our communities. Anchorless Records will be donating all the profits of All Aboard: A Tribute To Johnny Cash to the Syrentha Savio Endowment (SSE), a non-profit organization that provides financial assistance to underprivileged women who cannot afford the expense of fighting Breast Cancer. All Aboard features debut solo performances from Russ Rankin (former front man of seminal punk band Good Riddance), Joe McMahon of Smoke or Fire, and Ben Nichols of Lucero. The tribute also boasts The Bouncing Souls ... Source: ihealthbulletin.com --- 1 day ago
WVU.edu - Cancer Patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University, researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that Breast Cancer chemotherapy drugs sometimes induce. In the WVU researchers’ study, published in the September 2008 [...] ... Source: www.cancerribbons.info --- 4 hours ago
Lauren Muchko designed a black and pink necktie that won the $2,500 first prize in a National City contest supporting Breast Cancer Patients. ... Find more results for Breast Cancer Patients on RSSMicro.com |
Copyright © 2008 RSSMicro.com
Breast Cancer treatments can rob a person of dignity, identity and control. The whole experience of vulnerability is overwhelming. No one knows that better than North Andover resident and Breast Cancer survivor Cathy McGrath, who’s since designed a product that’s helped hundreds of Breast Cancer Patients feel a little better during what is often a harrowing experience. Along with fellow resident Maureen Cardinal, McGrath runs A Little Easier Recovery, a nonprofit company that provides hospitals with free stylish and comfortable Cancer recovery jackets designed by McGrath, called “Jackis.” The Jacki looks like a regular top, made from soft Polartec fleece, but inside it holds pockets for medical drains, offering Patients a chance to maintain a sense of normalcy in their lives during a challenging time. The recovery jacket helps improve post-op mobility and range of motion, allows easy access to IV lines, blood pressure readings, tests and injections, all while keeping the patient warm and comfortable. Nurse Coordinator Cate Mullen at the Breast Health Center at Tufts Medical Center in Boston has seen firsthand what it means to her Patients. “Each and every patient who used this product found it to be a useful and comforting item when comfort is otherwise at a minimum,” said Mullen. “The long hours spent waiting in drafty rooms wearing only a thin hospital Johnny can make Patients feel even worse than they already do. It robs them o ...